Conversion from sirolimus to everolimus in kidney transplant recipients:The experience in a medical center in Taiwan

• In: Posters
• At: Amsterdam (the Netherlands) (2012)
• Type: Poster
• Poster code: HPS-P-119
• By: WU, Chih-I (Changhua Christian Hospital, Pharmacy, Changhua, China Taiwan)
• Co-author(s): Chen, C.H. (Changhua Christian Hospital, Changhua, China Taiwan)
  Ng, S.P. (Changhua Christian Hospital, Changhua, China Taiwan)
  Chien, S.Y. (Changhua Christian Hospital, Changhua, China Taiwan)
  
• Abstract:

  
  Objectives

  This study investigated the optimal conversion dosage, efficacy and safety profile between everolimus (EVL) and sirolimus (SRL)

  Methods
  
  ?
  The open-label, single-center study includes 16 kidney transplant recipients conversion from SRL to EVL. We analyzed the medical records and laboratory data, including dosage, serum creatinine,

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login